El SARS-CoV-2 y la práctica dental
DOI:
https://doi.org/10.33448/rsd-v9i9.7884Palabras clave:
COVID-19, SARS-CoV-2, Odontología, Medicina dental.Resumen
El nuevo coronavirus (SARS-CoV-2) es de la subfamilia Betacoronavirus, altamente patógeno y responsable de causar síndrome respiratorio agudo severo. Puede transmitirse por contacto interpersonal a través de la inhalación de gotitas contaminadas o por contacto indirecto con una superficie contaminada. El consultorio dental puede ser un lugar de posible contaminación por la propagación de aerosoles que contienen saliva / sangre, además de un contacto muy cercano con el profesional y el equipo. El período de incubación del virus puede llegar a más de seis días, y la manifestación de la enfermedad puede incluir fiebre, tos, náuseas, vómitos, diarrea, dolor de cabeza, dolores musculares, entre otros síntomas; las pruebas de laboratorio demuestran linfocitopenia, leucopenia y aumento de la proteína C reactiva. Las medidas para protegerse contra la contaminación del nuevo coronavirus son necesarias incluso en pacientes que no presentan síntomas. Durante el período de distancia social propuesto como método para prevenir la propagación del virus, el cirujano dentista debe incorporar un cuidado extra en la prevención de la propagación de la enfermedad, utilizando equipos de protección personal y limpiando los equipos y el medio ambiente de manera adecuada. El estudio consistió en realizar una revisión de la literatura sobre el cuidado dental durante el período pandémico de COVID-19. De esta forma, corresponde a todos seguir los protocolos preventivos preestablecidos, apuntar a métodos de diagnóstico más accesibles a la población en general y esperar un sistema de inmunización eficaz.
Referencias
Adhikari, S. P., Meng, S., Wu, Y. J., Mao, Y. P., Ye, R. X., & Wang, Q. Z., et al. (2020). Epidemiology, causes, clinical manifestation and diagnosis, prevention and control of coronavirus disease (COVID-19) during the early outbreak period: a scoping review. Infectious diseases of poverty, 9(1), 29. https://doi.org/10.1186/s40249-020-00646-
Amato, A., Caggiano, M., Amato, M., Moccia, G., Capunzo, M., & De Caro, F. (2020). Infection Control in Dental Practice During the COVID-19. Pandemic. International journal of environmental research and public health, 17(13), 4769. https://doi.org/10.3390/ijerph17134769
Anvisa- Agência Nacional de Vigilância Sanitária. (2020) Nota técnica GVIMS/GGTES/ANVISA nº 04/2020 orientações para serviços de saúde: medidas de prevenção e controle que devem ser adotadas durante a assistência aos casos suspeitos ou confirmados de infecção pelo novo coronavírus (SARS-CoV-2).
Arendse, L. B., Danser, A., Poglitsch, M., Touyz, R. M., Burnett, J. C., & Jr, Llorens-Cortes, C., et al. (2019). Novel Therapeutic Approaches Targeting the Renin-Angiotensin System and Associated Peptides in Hypertension and Heart Failure. Pharmacological reviews, 71(4), 539–570. https://doi.org/10.1124/pr.118.017129
Askin, L., Tanrıverdi, O., & Askin, H. S. (2020). The Effect of Coronavirus Disease 2019 on Cardiovascular Diseases. O Efeito da Doença de Coronavírus 2019 nas Doenças Cardiovasculares. Arquivos brasileiros de cardiologia, 114(5), 817–822. https://doi.org/10.36660/abc.20200273
Bahramian, H., Gharib, B., & Baghalian, A. (2020). COVID-19 Considerations in Pediatric Dentistry. JDR clinical and translational research, 2380084420941503. Advance online publication. https://doi.org/10.1177/2380084420941503
Barry, M., Al Amri, M., & Memish, Z. A. (2020). COVID-19 in the Shadows of MERS-CoV in the Kingdom of Saudi Arabia. Journal of epidemiology and global health, 10(1), 1–3. https://doi.org/10.2991/jegh.k.200218.003
Bizzoca, M. E., Campisi, G., & Muzio, L. L. (2020). Covid-19 Pandemic: What Changes for Dentists and Oral Medicine Experts? A Narrative Review and Novel Approaches to Infection Containment. International journal of environmental research and public health, 17(11), 3793. https://doi.org/10.3390/ijerph17113793
BRASIL, Ministério da Saúde. (2006). Agência Nacional de Vigilância Sanitária. Serviços odontológicos; prevenção e controle de riscos. Brasília :Ministério da Saúde.
BRASIL, Ministério da Saúde. Protocolo de Tratamento do Novo Coronavírus (2019-nCoV). Brasília – DF 2020.
Campos, C. A. S., Neto, G. S. C.G., Pereira, R. S., Costa, M. O., Santos, W. B., & Rocha, W. G. et al. (2020) Biosafity in dentry: literature review. Braz. J. Hea. Rev., Curitiba, 3(2):1656-1662. ISSN 2595-6825. doi:https://10.34119/bjhrv3n2-027.
Cao, B., Wang, Y., Wen, D., Liu, W., Wang, J., & Fan, G. et al. (2020) A Trial of Lopinavir–Ritonavir in Adults Hospitalized with Severe Covid-19. N Engl J Med, 382(19):1787-1799. doi: 10.1056/NEJMoa2001282.
Chen, N., Zhou, M., Dong, X., Qu, J., Gong, F., & Han, Y. et al. (2020) Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet, 15;395(10223):507–513. doi: 10.1016/S0140-6736(20)30211-30217.
Cheng, H., Wang, Y., & Wang, G. Q. (2020). Organ-protective effect of angiotensin-converting enzyme 2 and its effect on the prognosis of COVID-19. J Med Virol, 92(7):726-730. doi:10.1002/jmv.25785
Cipitelli, M. C. Efeito das quimiocinas na alteração da permeabilidade de células endoteliais na dengue /Rio de Janeiro, 2014. Dissertação (Mestrado) – Instituto Oswaldo Cruz, Pós-Graduação em Biologia Parasitária,2014.
Colson, P., Rolain, J. M., Lagier, J. C., Brouqui, P., & Raoult, D. (2020). Chloroquine and hydroxychloroquine as available weapons to fight COVID-19. Hot Topic / International Journal of Antimicrobial Agents, 55:1-3. doi:tw/10.1016/j.ijantimicag.2020.105932
Cron, R. Q., & Chatham, W. W. (2020). The Rheumatologist's Role in Covid-19. J Rheumatol ;47(5):639-642. doi: 10.3899/jrheum.200334.
de Andrade, B. A., Padron-Alvarado, N. A., Muñoz-Campos, E. M., Morais, T. L., & Martinez-Pedraza, R. (2017) Hyperpigmentation of hard palate induced by chloroquine therapy. J Clin Exp Dent, 1;9(12):e1487-e1491. doi: 10.4317/jced.54387.
Feijoo, A. M., Maseda E, Bartolomé, R. A., Aguilar, G., González de Castro, R., & Gómez-Herreras, J. I., et al. (2020) Pratical recomendaciones prácticas para el manejo perioperato- rio del paciente con sospecha o infección grave por coronavirus SARS-CoV-2. Rev Esp Anestesiol Reanim, 67(5):253-260. doi: 10.1016/j.redar.2020.03.003.
Feng, S., Shen, C., Xia, N., Song, W., Fan, M., & Cowling, B. J. (2020). Rational use of face masks in the COVID-19 pandemic. Lancet Respir Med, 8(5):434-436. doi: 10.1016/S2213-2600(20)30134-X.
Folegatti, P. M., Ewer, K. J., Aley, P. K., Angus, B., Becker, S., & Belij-Rammerstorfer, S., et al. (2020). Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial. Lancet, 15;396(10249):467-478. doi: 10.1016/S0140-6736(20)31604-4.
Gautret, P., Lagier, J-C., Parola, P., Hoang, V. T., Meddeb, L., & Mailhe, M., et al. (2020). Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial. Int J Antimicrob Agents, 56(1):105949. doi: 10.1016/j.ijantimicag.2020.105949.
Guan, W., Ni, Z., Hu, Y., Liang, W., Ou, C., & He, J., et al. (2020). Clinical Characteristics of Coronavirus Disease 2019 in China. N Engl J Med, 30;382(18):1708-1720. doi: 10.1056/NEJMoa2002032.
Gupta, R., Ghosh, A., Singh, A. K., & Misra, A. (2020) Fast Track Article: Short Review Considerations for Patients with Diabetes in Times of COVID-19 Epidemic. Diabetes Metab Syndr, 14(3):211-212. doi: 10.1016/j.dsx.2020.03.002.
Horta-Baas, G. (2018). Chloroquine-induced oral mucosal hyperpigmentation and nail dyschromia. Reumatol Clin, 14(3):177-178. doi: 10.1016/j.reuma.2017.06.003.
Joob, B. & Wiwanitkit, V. (2020). COVID-19 can present with a rash and be mistaken for Dengue, J Am Acad Dermatol, 82(5):e177. doi: 10.1016/j.jaad.2020.03.036.
Kampf, G., Todt, D., Pfaender, S., & Steinmann, E. (2020). Persistence of coronaviruses on inanimate surfaces and their inactivation with biocidal agents. J Hosp Infect, 104(3):246-251. doi: 10.1016/j.jhin.2020.01.022.
Ko, W-C., Rolain, J-M., Leea, N-Y., Chen, P-L., Huange, C-T., L& eef, P-I., et al. (2020). Arguments in favour of remdesivir for treating SARS-CoV-2 infections. Int J Antimicrob Agents, 55(4):105933. doi: 10.1016/j.ijantimicag.2020.105933.
Lai, C. C., Shih, T. P., Ko, W. C., Tang, H. J., & Hsueh, P. R. (2020). Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): The epidemic and the challenges. Int J Antimicrob Agents, 55(3):105924. doi: 10.1016/j.ijantimicag.2020.105924.
Larson, E. L., Early, E., Cloonan, P., Sugrue, S., & Parides, M. (2000) An organizational climate intervention associated with increased handwashing and decreased nosocomial infections. Behav Med. Spring, 26(1):14-22. doi: 10.1080/08964280009595749.
Leite CC. A transformação no mercado de serviços odontológicos e as disputas pelo monopólio da prática odontológica no século XIX. Hist. cienc. saúde-Manguinhos 2006;13(1): 55-76. https://doi.org/10.1590/S0104-59702006000100004.
Lu, R., Zhao, X., Li, J., Niu, P., Yang, B., & Wu, H., et al. (2020) Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet, 395(10224):565-574. doi: 10.1016/S0140-6736(20)30251-8.
Lu, C. W., Liu, X. F., & Jia, Z. F. (2020). 2019-nCoV transmission through the ocular surface must not be ignored. The Lancet, (395). https://doi.org/10.1016/S0140-6736(20)30313-5)
Luan, R. S., Wang, X., Sun, X., Chen, X. S., Zhou, T., & Liu, Q. H., et al. (2020) Epidemiology, Treatment, and Epidemic Prevention and Control of the Coronavirus Disease 2019: a Review. Sichuan Da Xue Xue Bao Yi Xue Ban, 51(2):131-138. doi: 10.12182/20200360505.
Madjid, M., Safavi-Naeini, P., Solomon, S. D., & Vardeny, O.(2020) Potential Effects of Coronaviruses on the Cardiovascular System. JAMA Cardiology, E1-10. doi:10.1001/jamacardio.2020.1286
Meng, L., Hua, F. & Bian, Z.(2020). Coronavirus Disease 2019 (COVID-19): Emerging and Future Challenges for Dental and Oral Medicine. J Dent Res, 99(5):481-487. doi: 10.1177/0022034520914246
Meo, S. A., Alhowikan, A. M., Al-Khlaiwi, T., Meo, I. M., Halepoto, D. M., & Iqbal, M., et al. (2020). Novel coronavirus 2019-nCoV: prevalence, biological and clinical characteristics comparison with SARS-CoV and MERS-CoV. Eur Rev Med Pharmacol Sci, 24(4):2012-2019. doi: 10.26355/eurrev_202002_20379.
Morgado, M., Santos, D., & Mendes, S. (2017). Inibidores das Janus Associated Kinases na Terapêutica Farmacológica. Revista Portuguesa De Farmacoterapia, 9(1),21-34. https://doi.org/10.25756/rpf.v9i1.127.
Oliveira, R. H. G., & Almeida, T. F. (2015) Riscos Biológicos em Odontologia. Revista Bahiana de Odontologia, 6(1):34-46. doi:https:// 10.17267/2238-2720.
Organization WH. Laboratory testing for coronavirus disease 2019 (COVID-19) in suspected human cases: interim guidance, 2 March 2020. World Health Organization, 2020.
Peiris, J. S., Yuen, K. Y., Osterhaus, A. D., & Stohr, K. (2003). The severe acute respiratory syndrome. N Engl J Med, 349(25):2431-41. doi: 10.1056/NEJMra032498.
Peng, X., Xu, X., Li, Y., Cheng, L., Zhou, X., & Ren, B. (2020). Transmission routes of 2019-nCoV and controls in dental practice. Int J Oral Sci, 12(1):9. doi: 10.1038/s41368-020-0075-9.
Perico, L., Benigni, A., & Remuzzi, G. (2020). Should COVID-19 Concern Nephrologists?Why and to What Extent? The Emerging Impasse of Angiotensin Blockade. Nephron, 144(5):213-221. doi: 10.1159/000507305.
Prem, K., Liu, Y., Russell, T. W., Kucharski, A. J., Eggo, R. M., & Davies, N. (2020). The effect of control strategies to reduce social mixing on outcomes of the COVID-19 epidemic in Wuhan, China:a modelling study. Lancet Public Health, 5(5):e261-e270. doi: 10.1016/S2468-2667(20)30073-30076.
Qozi, M., & Cantrell, F. L. Chloroquine/Hydroxychloroquine. (2014). Encyclopedia of Toxicology.V1. (Third Edition),913-5. doi.org/10.1016/B978-0-12-386454-3.00710-7
René, M., & Costa, D. E. (1991) Da medicina do trabalho à saúde do trabalhador. Rev. Saúde Pública, 25(5):341-349. https://doi.org/10.1590/S0034-89101991000500003
Rossi, G. P., Sanga, V., & Barton, M. (2020). Potential harmful effects of discontinuing ACE-inhibitors and ARBs in COVID-19 patients Elife, 9:e57278. doi: 10.7554/eLife.57278.
Rothana, H. A., & Byrareddy, S. N. (2020). The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak. J Autoimmun, 109:102433. doi: 10.1016/j.jaut.2020.102433.
Sahraei, Z., Shabani, M., Shokouhi, S., & Saffaei, A. (2020). Aminoquinolines against coronavirus disease 2019 (COVID-19): chloroquine or hydroxychloroquine. Int J Antimicrob Agents. Apr;55(4):105945. doi: 10.1016/j.ijantimicag.2020.105945. Epub 2020 Mar 17.
Sakaguchi, W., Kubota, N., Shimizu, T., Saruta, J., Fuchida, S., & Kawata, A., et al.(2020) Existence of SARS-CoV-2 Entry Molecules in the Oral Cavity. Int. J. Mol. Sci, 21(17), 6000; https://doi.org/10.3390/ijms21176000
Siles-Garcia, A. A., Alzamora-Cepeda, A. G., Atoche-Socola, K. J., Peña-Soto, C., & Arriola-Guillén, L. E. (2020). Biosafety for Dental Patients During Dentistry Care After COVID-19: A Review of the Literature. Disaster medicine and public health preparedness, 1–6. Advance online publication. https://doi.org/10.1017/dmp.2020.252
Singh, A. K., Singh, A., Shaikh, A., Singh, R., & Misra, A. (2020). Chloroquine and hydroxychloroquine in the treatment of COVID-19 with or without diabetes: A systematic search and a narrative review with a special reference to India and other developing countries. Diabetes & metabolic syndrome, 14(3), 241–246. https://doi.org/10.1016/j.dsx.2020.03.011
Singhal T. (2020). A Review of Coronavirus Disease-2019 (COVID-19). Indian journal of pediatrics, 87(4), 281–286. https://doi.org/10.1007/s12098-020-03263-6
Skare, T., Ribeiro, C. F., Souza, F. H., Haendchen, L., & Jordão, J. M. (2011). Antimalarial cutaneous side effects: a study in 209 users. Cutaneous and ocular toxicology, 30(1), 45–49. https://doi.org/10.3109/15569527.2010.521225
To, K., Yip, C., Lai, C., Wong, C., Ho, D.,& Pang, P., et al. (2019). Saliva as a diagnostic specimen for testing respiratory virus by a point-of-care molecular assay: a diagnostic validity study. Clinical microbiology and infection: the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 25(3), 372–378. https://doi.org/10.1016/j.cmi.2018.06.009
Velavan, T. P., & Meyer, C. G. (2020). The COVID-19 epidemic. Tropical medicine & international health: TM & IH, 25(3), 278–280. https://doi.org/10.1111/tmi.13383
Wang, J., Peng, Y., Xu, H., Cui, Z., & Williams, R. O., 3rd (2020). The COVID-19 Vaccine Race: Challenges and Opportunities in Vaccine Formulation. AAPS PharmSciTech,21(6), 225. https://doi.org/10.1208/s12249-020-01744-7
Wang, W., Tang, J., & Wei, F. (2020). Updated understanding of the outbreak of 2019 novel coronavirus (2019-nCoV) in Wuhan, China. Journal of medical virology, 92(4), 441–447. https://doi.org/10.1002/jmv.25689
Wang, W., Xu, Y., Gao, R., Lu, R., Han, K., Wu, G., & Tan, W. (2020). Detection of SARS-CoV-2 in Different Types of Clinical Specimens. JAMA, 323(18), 1843–1844. Advance online publication. https://doi.org/10.1001/jama.2020.3786
Wong, S. H., Lui, R. N., & Sung, J. J. (2020). Covid-19 and the digestive system. Journal of gastroenterology and hepatology, 35(5), 744–748. https://doi.org/10.1111/jgh.15047
Wu, Z., & McGoogan, J. M. (2020). Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention. JAMA, 10.1001/jama.2020.2648.
Advance online publication. https://doi.org/10.1001/jama.2020.2648
Xi, Jin., Lian, J-S., Hu. J-H., Gao, J., Zheng, L., & Zhang, Y-M., et al. (2020). Epidemiological, clinical and virological characteristics of 74 cases of coronavirus-infected disease 2019 (COVID-19) with gastrointestinal symptoms. Gut, 69(6):1002-1009. doi: 10.1136/gutjnl-2020-320926.
Xu, H., Zhong, L., Deng, J., Peng, J., Dan, H., & Zeng, X., et al. (2020). High expression of ACE2 receptor of 2019-nCoV on the epithelial cells of oral mucosa. International journal of oral science, 12(1), 8. https://doi.org/10.1038/s41368-020-0074-x
Xu, J., Zhao, S., Teng, T., Abdalla, A. E., Zhu, W., & Xie, L., et al. (2020). Systematic Comparison of Two Animal-to-Human Transmitted Human Coronaviruses: SARS-CoV-2 and SARS-CoV. Viruses, 12(2), 244. https://doi.org/10.3390/v12020244
Yamey, G., Schäferhoff, M., Hatchett, R., Pate, M., Zhao, F., & McDade, K. K. (2020). Ensuring global access to COVID-19 vaccines. Lancet (London, England), 395(10234), 1405–1406. https://doi.org/10.1016/S0140-6736(20)30763-7
Yang, X., Yu, Y., Xu, J., Shu, H., Xia, J., & Liu, H., et al. (2020). Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. The Lancet. Respiratory medicine, 8(5), 475–481. https://doi.org/10.1016/S2213-2600(20)30079-5
Zhang, C., Wu, Z., Li, J. W., Zhao, H., & Wang, G. Q. (2020). Cytokine release syndrome in severe COVID-19: interleukin-6 receptor antagonist tocilizumab may be the key to reduce mortality. International journal of antimicrobial agents, 55(5), 105954. https://doi.org/10.1016/j.ijantimicag.2020.105954
Zhang, C., Huang, S., Zheng, F., & Dai, Y. (2020). Controversial treatments: An updated understanding of the coronavirus disease 2019. Journal of medical virology, 10.1002/jmv.25788. Advance online publication. https://doi.org/10.1002/jmv.25788
Zhang, W., & Jiang, X.(2020). Measures and suggestions for the prevention and control of the novel coronavirus in dental institutions. Front Oral Maxillofac Med, 2:4 http://dx.doi.org/10.21037/fomm.2020.02.01
Zhang, W., Zhao, Y., Zhang, F., Wang, Q., Li, T., & Liu, Z., et al. (2020). The use of anti-inflammatory drugs in the treatment of people with severe coronavirus disease 2019 (COVID-19): The Perspectives of clinical immunologists from China. Clinical immunology (Orlando, Fla.), 214, 108393. https://doi.org/10.1016/j.clim.2020.108393
Zhou, F., Yu, T., Du, R., Fan, G., Liu, Y., Liu, Z., & Xiang, J., et al. (2020). Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet (London, England), 395(10229), 1054–1062. https://doi.org/10.1016/S0140-6736(20)30566-3
Zhou, P., Yang, X. L., Wang, X. G., Hu, B., Zhang, L., & Zhang, W., et al. (2020). A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature, 579(7798), 270–273. https://doi.org/10.1038/s41586-020-2012-7
Zhu, N., Zhang, D., Wang, W., Li, X., Yang, B., & Song, J., et al. (2020). A Novel Coronavirus from Patients with Pneumonia in China, 2019. N Engl J Med, 382(8), 727–733. https://doi.org/10.1056/NEJMoa2001017
Descargas
Publicado
Número
Sección
Licencia
Derechos de autor 2020 Michelly Cauás de Queiroz Gatis; Livia Mirelle Barbosa; João Luiz Gomes Carneiro Monteiro; Thaisa Reis de Carvalho Sampaio; José Brasiliense Holanda Cavalcanti Filho; Belmiro Cavalcanti do Egito Vasconcelos
Esta obra está bajo una licencia internacional Creative Commons Atribución 4.0.
Los autores que publican en esta revista concuerdan con los siguientes términos:
1) Los autores mantienen los derechos de autor y conceden a la revista el derecho de primera publicación, con el trabajo simultáneamente licenciado bajo la Licencia Creative Commons Attribution que permite el compartir el trabajo con reconocimiento de la autoría y publicación inicial en esta revista.
2) Los autores tienen autorización para asumir contratos adicionales por separado, para distribución no exclusiva de la versión del trabajo publicada en esta revista (por ejemplo, publicar en repositorio institucional o como capítulo de libro), con reconocimiento de autoría y publicación inicial en esta revista.
3) Los autores tienen permiso y son estimulados a publicar y distribuir su trabajo en línea (por ejemplo, en repositorios institucionales o en su página personal) a cualquier punto antes o durante el proceso editorial, ya que esto puede generar cambios productivos, así como aumentar el impacto y la cita del trabajo publicado.
